King Wealth Management Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
FM
King Wealth Management Group's ANAB Position: Q2 2019 in Review
King Wealth Management Group sold out of AnaptysBio (ANAB) in Q2 2019, closing a stake of 2,900 shares — an estimated $212K sold.
King Wealth Management Group first reported a position in ANAB in Q4 2018 and held it in 2 quarters. The position peaked at $249K in Q4 2018. 127 funds tracked by Wall St. Rank hold ANAB as of Q2 2019.
- King Wealth Management Group reported no remaining AnaptysBio position as of Q2 2019 after selling out during the quarter.
- King Wealth Management Group sold 2,900 AnaptysBio shares in Q2 2019, an estimated $212K.
- King Wealth Management Group first reported a position in AnaptysBio in Q4 2018 and held it in 2 quarters.
- King Wealth Management Group's AnaptysBio position peaked at $249K in Q4 2018.
- 127 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2019.
Based on King Wealth Management Group's 13F filing for Q2 2019, filed 13 Aug 2019.